INTRODUCTION
A fundamental problem in biology is the insertion of proteins into biological membranes. This problem is further complicated in eukaryotic cells by an extensive array of intracellular organelles that necessitates highly selective targeting to one among many membrane systems. For membrane protein biogenesis at the ER, the most wellstudied mechanism is a cotranslational insertion pathway mediated by the cytosolic signal recognition particle (SRP), the ER-localized SRP receptor (SR), and an ER protein translocon whose central channel is formed by the Sec61 complex (Shan and Walter, 2005; Osborne et al., 2005) . These basic components are highly conserved from bacterial to mammalian systems and are demonstrated to play an essential role in the biosynthesis of a wide range of membrane proteins.
Although ubiquitous, this cotranslational SRP-dependent pathway is inaccessible to a large class of membrane proteins whose only targeting information is encoded in a single transmembrane domain (TMD) close to the C terminus (Kutay et al., 1993; Wattenberg and Lithgow, 2001; Borgese et al., 2003; High and Abell, 2004) . These tailanchored (TA) proteins are released from the ribosome before the TMD emerges from the ribosomal tunnel (which shields 30-40 residues), precluding cotranslational targeting and translocation. TA proteins are surprisingly abundant in various membrane systems of the eukaryotic cell and play critical roles in nearly all aspects of cell biology . Notable examples include the SNAREs involved in vesicular trafficking, several components of translocons in various organelles, components of membrane-bound degradation machinery, structural proteins for Golgi morphology, and numerous enzymes whose activities are spatially restricted in the cell. Despite this broad functional importance of TA proteins, the pathways by which they are targeted to or inserted into the ER membrane remain very poorly understood.
With some exceptions (such as cytochrome b5 [Cb5]), most ER-targeted TA proteins are thought to be inserted via an energy-dependent process that involves at least one proteinaceous component of the ER. Early reconstitution studies suggested convincingly that components of the ER other than the minimal cotranslational machinery (SR, Sec61, and translocating chain-associating membrane protein [TRAM] ) were necessary for insertion of the model TA protein synaptobrevin (Kutay et al., 1995) . Since that time, a variety of studies have confirmed an ATP requirement for several other TA proteins, provided further support for yet unidentified membrane factors, and characterized some of the sequence requirements for TMD insertion (Kutay et al., 1995; Whitley et al., 1996; Kim et al., 1997 Kim et al., , 1999 Steel et al., 2002; Borgese et al., 2001; Abell et al., 2003) . These biochemical analyses were buttressed with studies in yeast showing that various mutants in the known co-or posttranslational translocation pathways are not impaired in TA protein insertion (Steel et al., 2002; Yabal et al., 2003) . While recent crosslinking analyses were used to suggest interactions between TA proteins and components of the SRP and Sec61 pathways (Abell et al., 2003 , the functional relevance of these observations remains largely uncertain and in contradiction to previous studies arguing against a role for these components (e.g., Kutay et al., 1995) . Thus, the main consensus from the sum of the available studies is that components in the cytosol and membrane, at least one of which may be dependent on ATP, are involved in insertion. However, the identity of the ATP-requiring component(s), the membrane receptor(s), and their mechanisms of action have long remained elusive.
Clarification of these issues will require identification of components in the pathway of insertion. A major obstacle to achieving this goal has been the heterogeneity of insertion assays that rely on measuring membrane binding of TA proteins. A binding assay can contribute significant background noise by not reliably distinguishing a physiologically relevant membrane-spanning orientation from other modes of membrane association, insertion, or aggregation. Hence, the small dynamic range, low throughput, and low sensitivity of this assay have precluded significant attempts at identification of components involved in either targeting or insertion. Recently, this obstacle was overcome by a protease protection assay that not only showed high sensitivity and specificity, but could be employed in combination with fractionation of the lysate components (Brambillasca et al., 2005) . This approach greatly facilitated a detailed analysis of Cb5 insertion by the spontaneous pathway (defined here as not requiring any protein factors in the membrane). This study revealed a previously unappreciated ER dependence on lipid composition for insertion of Cb5. Exploiting this advance in methodology, we have now dissected the more broadly utilized, but poorly understood, nonspontaneous TA insertion pathway to identify a key cytosolic component of a TMD recognition complex (TRC) that functions in posttranslational membrane protein targeting. Our results delineate the principal steps in posttranslational membrane protein insertion, allow us to propose a working mechanistic framework for this ubiquitous and physiologically important pathway, and explain how the TRC-and SRPdependent pathways operate in parallel without crossinterference.
RESULTS AND DISCUSSION

TA Protein Insertion by an Energy-Dependent Protein-Requiring Pathway
The requirements for transmembrane insertion of a model TA protein were analyzed in vitro. The ER translocon component Sec61b was chosen because it is unambiguously inserted solely into the ER, is not trafficked elsewhere, is definitively confirmed to fully span the membrane (as opposed to a hairpin topology), and is highly conserved and universally expressed (Hartmann et al., 1994; Toikkanen et al., 1996; Van den Berg et al., 2004) . Hence, Sec61b insertion almost certainly utilizes a general and widely applicable ER-selective pathway whose components are likely to be found in all cells, making its analysis in heterologous in vitro systems physiologically relevant.
Using a recently developed protease protection assay (see Figure S1A in the Supplemental Data), an epitopetagged Sec61b (referred to hereafter as just Sec61b; see Table S1 in the Supplemental Data) synthesized in a reticulocyte lysate was found to insert posttranslationally into ER-derived rough microsomes (RMs). Correct transmembrane orientation was verified by recovery of a protease protected fragment (PF) representing the epitope-tagged transmembrane segment ( Figures 1A and 1B) . The PF was not observed when RMs were omitted, if detergent was included in the protease digestion reaction, or if the TMD was deleted from Sec61b (Figures 1A and 1B; Figures S1B and S1C) . The choice of epitope tag did not influence the insertion ( Figure S1C ), and the PF was confirmed in sedimentation assays to cofractionate with RMs (data not shown). Quantitation by phosphorimaging (after accounting for methionine distribution) showed better than 50% absolute insertion efficiency.
Using the generation of PF as a diagnostic marker for correct transmembrane orientation, Sec61b insertion was shown to occur at temperatures above 24 C, was complete within 15 min at 32 C, and was stimulated significantly by an energy regenerating system (Figures 1B and 1C) . Using a panel of previously characterized fractionated proteoliposomes and liposomes (see Table S2 ), we analyzed the membrane requirements for Sec61b insertion. These experiments showed that Sec61b inserts efficiently into proteoliposomes reconstituted from total ER membrane proteins (rRM), but not liposomes ( Figure 1D ; Figures S1C-S1E) or protease-digested proteoliposomes ( Figure 1E ). This contrasted with Cb5, whose spontaneous transmembrane insertion into liposomes (or proteasedigested proteoliposomes) appears to occur by a pathway not available to Sec61b (Figures 1D and 1E, and Figures S1D and S1E; Brambillasca et al., 2005) .
Analyses in various fractionated proteoliposomes ( Figure 1F ; Table S2) suggested that depletion of known translocon components by 95% or more was without effect on Sec61b insertion. These depletions included the Sec61 complex, TRAM, the TRAP complex, Sec62, Sec63, oligosaccharyl transferase, and signal peptidase complex. Conversely, proteoliposomes containing only the SR and Sec61 complex failed to support Sec61b insertion even though they were competent for cotranslational translocation of Prl and posttranslational insertion of Cb5 ( Figure 1D ). Furthermore, modification of free cysteines on the ER membrane (which inhibits cotranslational translocation by modification of the SR; Andrews et al., 1989) had no effect on Sec61b insertion ( Figure 1G ) despite complete blockage of cotranslational translocation ( Figure 1H ). Considered together, these findings demonstrate that like synaptobrevin (Kutay et al., 1995) , insertion of Sec61b occurs by an energy-stimulated, protein-dependent, posttranslational mechanism that appears to be distinct from the known cotranslational or spontaneous insertion pathways.
Detection of a Cytosolic Targeting Complex for TA Protein Insertion
To find potential components involved in TA protein insertion, we took an unbiased approach utilizing a combination of fractionation, crosslinking, and functional insertion C with or without ER-derived rough microsomes (RM) and analyzed by a protease protection assay ( Figure S1A ) using proteinase K (PK). The precursor (pPrl) and processed (Prl) forms of Prolactin are indicated, as are the full length (FL) and protected fragment (PF) species of Sec61b. The diffuse band just above Sec61b is hemoglobin from the reticulocyte lysate.
(B) Lanes 1-4 are immunoprecipitates (against a C-terminal epitope tag; see Figure S1A ) of translocation reactions as in (A). Lanes 5-12 are Sec61b translation products (without RMs, as in lane 3) that were posttranslationally incubated with RMs at the indicated temperatures for between 0 to 60 min before analysis by PK digestion and immunoprecipitation to recover the PF. (C) Sec61b translated without RM was isolated by immunoaffinity chromatography (to remove free nucleotides), and the eluted products were tested for insertion into RM in the absence or presence of an energy regenerating system. Quantification by phosphorimaging showed 3-fold increased insertion with energy.
(D) Cotranslational translocation of Prl and posttranslational insertion of Sec61b and Cb5 were tested with the indicated membrane vesicles (see Table S2 ) using a protease protection assay. This Cb5 construct (see Table S1 ) has a glycosylation site at the C terminus that is modified upon insertion into RM (and to a small extent, in rRM). The lack of Prl processing in Sec61/SR proteoliposomes is due to the absence of signal peptidase.
(E) Time course (at 25 C) of Sec61b and Cb5 insertion into rRM (solid lines) or rRM-PK (reconstituted from PK-digested ER membrane proteins).
(F) Posttranslational insertion of Sec61b was tested with the indicated membrane vesicles (see Table S2 ). Only the protease-digested, immunoprecipitated samples are shown.
(G and H) RM treated with Biotin-maleimide (to modify exposed sulfhydryls) and mock-treated RM was tested for cotranslational translocation of Prl and posttranslational insertion of Sec61b and Cb5. In addition to protease protection, Cb5 insertion and Prl translocation can also be observed by their glycosylation and signal cleavage, respectively.
analyses. We reasoned that during targeting, TA protein substrates are likely to engage a targeting complex that, at the very least, prevents exposure of the hydrophobic TMD to the aqueous environment. Indeed, sucrose velocity gradient analyses (Figure 2A ) of in-vitro-synthesized Sec61b at a step prior to the addition of RMs showed it to be in very heterogeneous complexes ranging from 4 S to 11 S (roughly 100 to more than 500 kDa). Formation of these complexes was dependent on the TMD, but was not influenced by the presence or placement of epitope tags ( Figure S2A and data not shown). Analysis of each fraction by chemical crosslinking revealed a variety of crosslinking partners, the most prominent of which was an 40 kDa protein found largely in fractions 4 through 7 ( Figure 2B ). These crosslinks were observed with various concentrations of both lysine-and cysteine-reactive crosslinkers, not seen with Sec61b lacking the TMD, and not influenced by the choice or location of epitope tags ( Figures S2B and S2C) . Importantly, the peak fractions containing this crosslink were clearly separated from peak fractions containing SRP (in which crosslinks to SRP54 were not detectable; Figure S2D ). The interaction with p40 was highly sensitive to detergent ( Figure S2E ), but relatively stable in the presence of elevated salt (to 250 mM; data not shown), suggesting predominantly hydrophobic-based interactions consistent with involvement of the substrate's TMD.
The peak p40-containing fraction displayed noticeably higher efficiency of insertion when compared with the peak SRP-containing fraction ( Figure 2C ), suggesting the possibility that the p40-Sec61b complex is an insertion-competent intermediate. To test this idea, we performed crosslinking analyses before and immediately after incubation with membrane vesicles. We reasoned that a bona fide intermediate complex would disassemble concomitant with insertion, whereas off-pathway complexes would be maintained as a noninserted population ( Figure 2D ). Crosslinks between Sec61b and p40 disappeared concomitant with membrane insertion into either RM or rRM, but not after incubation with insertionincompetent liposomes (Figures 2E and 2F) . Other crosslinks were observed to remain unchanged regardless of membrane incubations ( Figure S2F ), suggesting that these (relatively minor) interactions represent populations of Sec61b that are not on the productive insertion pathway. Based on the TMD-dependent interaction with Sec61b at a step before (but not after) insertion, we hypothesized that p40 may represent a component of a TA protein-targeting machinery that we have termed TRC. This 40 kDa component, which will be the focus of the remainder of this study, will subsequently be called TRC40.
Identification and Characterization of TRC40 as a Component of TRC
To identify TRC40, we affinity-purified the in-vitro-generated Sec61b-TRC complex ( Figure 3A ) using anti-peptide antibodies directed against the extreme N terminus of Sec61b under conditions predetermined to preserve integrity of the complex. Upon peptide-elution under physiologic conditions, the recovered material was confirmed by sucrose gradient analyses ( Figure 3B ) to still be in similarly sized complexes as before, to display similar crosslinking patterns (data not shown), and importantly, to insert into RM in an energy-stimulated manner (data not shown; cf. Figure 1C) . Comparison of the affinity-purified complex to a parallel sample using Sec61b lacking the TMD revealed a TMD-specific 40 kDa band by silver staining ( Figure 3C ). Large-scale translations were subjected to the same procedure and the 40 kDa product (recovered in a roughly 1:1 stoichiometry with Sec61b; Figure 3C ) was identified by mass spectrometry of the tryptic digests. Seven independent peptide fragments matched the predicted sequence for a 348 amino acid protein that contains a highly conserved N-terminal ATPase domain and a C-terminal region containing a conserved hydrophobic patch ( Figure 3D ; Figures S3A and S3B). This protein was originally annotated Asna-1 in mammals due to 27% homology to a bacterial ATPase (ArsA) involved in arsenite transport (Kurdi-Haidar et al., 1996) . However, these and subsequent authors have found little or no arsenite-stimulated ATPase activity (Kurdi-Haidar et al., 1998; Mukhopadhyay et al., 2006) , and conclude that the mammalian protein plays a different role than its distant bacterial homolog. Although knockout of Asna-1 in mice results in early embryonic lethality (Mukhopadhyay et al., 2006) , its function has remained unknown. Based on our functional results below, we propose the name TRC40 for this protein.
Two synthetic peptides from the predicted sequence of TRC40 were used to raise antibodies that confirmed the specific presence of TRC40 in the affinity-purified (A) Sec61b and Sec61b(DTMD) were translated in vitro and isolated by immunoaffinity purification under native conditions. The top and bottom panels show the Coomassie-stained gel and autoradiograph, respectively, of samples taken at each step in the purification. (B) Sucrose velocity gradient analysis of immunoaffinity-purified Sec61b (from A) shows a sedimentation profile similar to the starting sample (compare to Figure 2A ) and distinct from constructs lacking the TMD ( Figure S2A ). (C) Immunoaffinity-purified Sec61b and Sec61b(DTMD) were analyzed by silver staining (left panel). Sample from a 20-fold larger scale preparation of Sec61b was also analyzed by Coomassie staining (right). The positions of p40 and Sec61b (verified by mass spectrometry) are indicated. (D) Sequence of TRC40. Tryptic peptides obtained by mass spectrometry are underlined, peptides used for raising antibodies are boxed, the ATPase domain is in blue, and a conserved hydrophobic patch in the C-terminal region is green. (*) indicates the glycine mutated to generate the ATPase-deficient mutant used in Figure 6 . (E) Immunoblots for TRC40, SRP54, and Hsp70 of immunoaffinity-purified Sec61b and Sec61b(DTMD) complexes prepared as in (A). Different amounts of reticulocyte lysate (0.2 to 1 ml) were included on the same gel as the purified complexes derived from 5 ml and 30 ml of translation reactions to estimate yield. An autoradiograph to confirm equal recovery of the translation products is shown in the bottom panel. Sec61b and Sec61b(DTMD) were treated with the sulfhydryl reactive crosslinker and immunoprecipitated under denaturing conditions using the indicated antibodies. Anti-GFP served as a nonspecific antibody control. In other experiments, the preimmune sera from the anti-TRC40 rabbits was used as a specificity control with identical results. The Sec61b(DTMD) autoradiograph is intentionally overexposed to illustrate complete lack of crosslinks to TRC40. (B) Constructs encoding Sec61b or Cb5(69C)-3F4, each containing a single cysteine in a comparable position, were analyzed in parallel by crosslinking and immunoprecipitation for interaction with TRC40. The weak crosslink between Cb5(69C)-3F4 and TRC40 could be observed only on longer exposures (right). (C) CFP-Sec61b and Sec61b-CFP were analyzed in parallel for crosslinking to TRC40. The double band is likely a consequence of crosslinks between different residues. (D) The indicated Nsyn1 constructs containing tails of various lengths from 3 to 154 residues were analyzed by crosslinking and immunoprecipitation of TRC40. No systematic differences among these constructs in crosslinking efficiencies to TRC40 were observed. (E) Reticulocyte lysate was separated into ribosomal and soluble (S-100) fractions that were analyzed by immunoblots for TRC40, SRP54, and Hsp70. Ten-fold more ribosomes relative to S-100 were analyzed. (F) Nsyn-108 was either synthesized completely (terminated) or made as a ribosome-nascent chain complex (RNC), both of which were analyzed by crosslinking. Samples were either analyzed directly (''total'') or after immunoprecipitation for TRC40. The indicated samples were treated with RNase Sec61b-TRC complex ( Figure 3E ). Of particular importance, TRC40 was not observed in parallel samples using Sec61b lacking the TMD. Neither Hsp70 nor SRP54 were found in appreciable quantities in the Sec61b-TRC complex ( Figure 3E and Figure S3C ; see Supplemental Data). Furthermore, both the N-and C-terminal anti-TRC40 antibodies could specifically immunoprecipitate the Sec61b-TRC40 crosslink, while neither nonspecific antibodies nor the preimmune sera was able to do so ( Figure 4A ; data not shown). Finally, immunoblotting revealed that TRC40 migrates in the position of the sucrose gradient in which the 40 kDa crosslinks were most prominently observed ( Figure 3F ; compare with Figure 2B) . Thus, the identified TRC40 protein is indeed the prominent 40 kDa crosslinking partner of TA proteins observed in Figure 2 .
As expected for a component of a general TA protein targeting complex, TRC40 is highly conserved in all eukaryotes ( Figure S3A ; comparable to the level of Sec61a conservation) and appears to be expressed universally in all tissues and cultured cell lines examined so far ( Figure 3G ). Our conservative estimate for the abundance of TRC40 in reticulocyte lysate is at least 20-50 nM, several-fold higher than the estimated abundance of cytosolic SRP (5-10 nM). Because the migration of TRC40 in the sucrose gradient was unchanged in the presence or absence of Sec61b, its assembly into the larger TRC would seem to not be induced by a TA substrate. This supposition was supported by specific crosslinks between TRC40 and several other reticulocyte lysate proteins that were maintained through various fractionation procedures ( Figures S3D and S3E ). While the identification of the additional component or components await complete purification of native TRC, these results allow us to conclude that TRC40 is one component of a larger preassembled complex that interacts with Sec61b in a TMD-dependent manner prior to its insertion into the ER membrane.
Selectivity of TRC40 Interactions with TA Protein Substrates
Several TA and non-TA proteins were analyzed by crosslinking and immunoprecipitation for their interaction with TRC40 (summarized in Figure 4G ). This analysis revealed that deletion of the TMD from Sec61b completely abolished any detectable interaction with TRC40 ( Figure 4A ), while other TA proteins that are inserted by a nonspontaneous posttranslational pathway ( Figure S4A ) were readily crosslinked to TRC40 ( Figure S5 and data not shown). By contrast, interaction of TRC40 with the spontaneously inserting Cb5 was markedly reduced relative to Sec61b ( Figure 4B ). Importantly, no interactions could be detected with the cotranslational translocation substrates Prolactin (Prl) or the prion protein (PrP) despite the fact that these proteins contain hydrophobic domains ( Figure S5 ). Both contain an N-terminal signal sequence, and PrP additionally contains an internal (potential) membrane spanning domain and C-terminal hydrophobic domain used for glycosylphosphatidylinositol (GPI) anchor addition. Thus, even though Prl, PrP, and Cb5 are observed by sucrose gradient analyses to be in high molecular weight complexes in the cytosol (data not shown), these complexes do not seem to include TRC40 as a principal interacting component. This suggested that TRC40-substrate interactions are more selective than simple hydrophobicity, and pointed to a context-dependent TMD-mediated interaction.
To test this idea directly, we examined TRC40 interactions with Sec61b constructs appended with cyan fluorescent protein (CFP) at either the N or C terminus (termed CFP-Sec61b and Sec61b-CFP, respectively). Although both constructs are inserted into the ER membrane, Sec61b-CFP is strictly cotranslational, while CFPSec61b is inserted posttranslationally ( Figure S4B ). Remarkably, TRC40 crosslinks were selectively observed with CFP-Sec61b ( Figure 4C ), even though both constructs contain identical sequence elements, including the TMD. Thus, TRC40 displays selectivity not only for certain TMDs, but also for the context in which these TMDs are found.
However, the contextual cue or cues appear to be more complex than simply a TMD at the C terminus. This became evident when we analyzed a member of the syntaxin family (most of which are TA proteins) from Neurospora crassa (Nsyn1) that had evolved an unusually long 154 residue C-terminal tail (Gupta et al., 2003) . Nsyn1 constructs containing tails ranging from 3 to 154 residues (termed Nsyn-3 through Nsyn-154) all showed essentially identical crosslinking efficiency to TRC40 ( Figure 4D ). While this would seem to be at odds with the Sec61b-CFP result above, it could be explained by our observation that Nsyn-108 and Nsyn-154 are capable of posttranslational insertion despite their unusually long tails ( Figure S4C ). When considered together, these findings reveal a striking relationship between a substrate's interaction with TRC40 and its ability to be integrated into the ER by the nonspontaneous posttranslational membrane protein insertion pathway. We therefore suggest that TRC40 has a context-dependent specificity for TMDs in membrane proteins that utilize this posttranslational pathway of insertion. While this pathway is most widely used by TA proteins that cannot access the cotranslational insertion pathway, it seems that at least some substrates that ordinarily would immediately prior to SDS-PAGE to remove any attached tRNA. The peptidyl-tRNA in the RNC sample verified that Nsyn-108 was ribosome associated at the time of crosslinking. (G) Summary of all TRC40 crosslinking analyses and functional properties of various constructs. Schematic representations of constructs are shown and aligned by their relative TMD position. Spontaneous insertion is defined as the ability to insert into liposomes (e.g., Cb5 in Figure 1D ). DN inhibition refers to the ability of a TRC40 dominant-negative protein to inhibit insertion (see Figure 6 ). n/a indicates not applicable (e.g., TA proteins cannot insert cotranslationally and an RNC cannot be tested posttranslationlly), and nd indicates not done.
use the SRP pathway (e.g., Nsyn1, which is not formally a TA protein) can also take advantage of the TRC pathway under some circumstances.
Hierarchical Interactions of Membrane Proteins with SRP and TRC40
The ability of TRC40 to interact with a substrate (Nsyn1) containing an internal TMD raised the issue of precisely when and where TRC40 first engages substrate relative to the other principal TMD recognition factor, SRP. Since the TMD of Nsyn1 would emerge from the ribosome long before reaching its termination codon, it is feasible in this instance for TRC40 to bind the nascent (i.e., ribosomeassociated) polypeptide. Even for a C-terminal TMD, binding might occur as it emerges from the ribosomal exit tunnel (e.g., if TRC were positioned there) to prevent exposure of the TMD to the aqueous cytosolic environment.
To examine these ideas, we first examined the localization of TRC40 in reticulocyte lysate. Unlike either SRP or Hsp70 (both of which are known nascent chain binding proteins; Krieg et al., 1986; Frydman et al., 1994) , TRC40 was not found in association with ribosomes to any appreciable degree ( Figure 4E ). This raised the possibility that interaction of TRC40 with substrates occurs only upon complete release from the ribosome into the cytosol. Indeed, Nsyn-108 was found in a complex with TRC40 after termination of translation, but not while it was a nascent peptidyl-tRNA bound to ribosomes (at which step other crosslinks were seen; Figure 4F ). This result indicates that when hydrophobic domains such as TMDs first emerge from the ribosome, they are likely to be preferential substrates for SRP. This is because the signal recognition cleft of SRP is poised at the ribosomal exit tunnel, effectively creating a very high local concentration (Halic et al., 2004) . Upon release from the ribosome, however, a suitably positioned TMD (i.e., in the context of a TA protein) is now a far better substrate for interaction with TRC. This is probably a combination of both a higher free cytosolic concentration of TRC relative to SRP and possibly a higher affinity of interaction in the nonribosomal context. We conclude from the above analyses that upon release of a TMD-containing protein from the ribosome, it is preferentially recognized by TRC, while ribosomeassociated nascent chains containing TMDs are preferentially recognized by SRP. Thus, these two complexes, which can recognize TMDs, do not interfere or compete with each other for substrate.
Reversible Binding of TRC40 to the ER Membrane
A key role for a putative targeting factor such as TRC would be its regulated binding and release from membranes competent for insertion of TA proteins. Indeed, immunoblots revealed that RMs contain substantial amounts of peripherally associated TRC40 that can be extracted by low salt, high pH (11.5), urea (2M), or small amounts of detergent ( Figure 5A and data not shown). Fractionation of liver under physiologic conditions suggested that at steady state, 30%-60% of TRC40 is bound to membranes ( Figure 5B ). Notably, a significant amount of this membrane-bound population of TRC40 could be released from the membrane under physiologic conditions upon brief (10 min) incubation with ATP ( Figure 5B ). This raised the possibility that the ATPase activity of TRC40 might play a role in the putative TRC targeting cycle. Thus, in addition to being free in the cytosol, endogenous TRC40 can also be found in a membranebound form that may represent association with a membrane-localized receptor. Consistent with this idea, in-vitro-synthesized TRC40 was observed to bind ER membranes, but not liposomes (data not shown). ATPase-Dependent Transfer of TA Proteins from TRC40 to the ER Membrane The transient interaction of TRC40 with both TA proteins and a putative ER-localized receptor pointed to a possible targeting function in which TRC delivers its substrates for subsequent membrane insertion. Attempts to demonstrate this proposed functional role by immunodepletion of TRC40 were hindered because neither of our anti-TRC40 antibodies recognized the native protein. We therefore took another approach. The energy dependence of TA protein insertion (Kutay et al., 1995;  Figure 1C ), together with the observations that TRC40 is an ATPase whose membrane binding is influenced by ATP (Figure 5C ), suggested to us a model in which ATP hydrolysis coordinates the targeting step (analogous to the use of GTPases in the SRP-dependent targeting pathway). We therefore reasoned that if TRC40 indeed plays a direct role in targeting, an ATPase-deficient mutant may act to dominantly and selectively inhibit TA protein insertion.
A glycine to arginine point mutant in the highly conserved ATP binding pocket of TRC40 (shown previously to disrupt ATPase activity; Shen et al., 2003) was recombinantly expressed, purified, and added at submicromolar concentrations to various translocation reactions. While this mutant (termed TRC40-DN, for dominant-negative) had no effect on cotranslational translocation of Prl ( Figure 6A ), it dose-dependently inhibited the posttranslational insertion of Sec61b and other TA proteins ( Figure 6A ). When added to posttranslational translocation reactions of signal sequence-containing a-factor across yeast microsomes ( Figure 6B ), TRC40-DN had no effect (except a slight nonspecific effect on translation at the highest concentrations). Furthermore, TRC40-DN had only a modest effect on the spontaneously inserting Cb5 substrate ( Figure 6C ). Considered together, these results indicate that the ATPase-deficient TRC40 dominantly inhibits the principal TA protein insertion pathway without substantial effects on the known cotranslational (Gorlich and Rapoport, 1993) , posttranslational (Panzner et al., 1995) , or spontaneous (Brambillasca et al., 2005) translocation pathways. These functional effects correlated well with the crosslinking results ( Figure 4G ): those substrates that interact with TRC40 are inhibited by the ATPase mutant, while substrates like Prl that do not interact with TRC40 are not inhibited. The partial effect on Cb5 is again consistent with its apparently weak interaction with TRC40 ( Figure 4B ) and its access to the alternate spontaneous insertion pathway (Brambillasca et al., 2005) .
The high level of TRC40 selectively for only the posttranslational membrane insertion pathway was analyzed in another way by examining Nsyn-108, a substrate that is normally inserted cotranslationally, but is also capable of posttranslational insertion after ribosome release ( Figure S4C ). Addition of TRC40-DN to cotranslational translocation reactions of Nsyn-108 had little effect on its membrane integration ( Figure 6D ). By striking contrast, insertion of this same substrate into the same membranes was inhibited potently by TRC40-DN if the reaction was performed posttranslationally. This result argues strongly for the existence of distinct parallel membrane insertion pathways that utilize different subsets of components, among which TRC40 is selectively posttranslational. Identical results were obtained with Nsyn-154 (data not shown).
Based on these findings, we surmised that the mechanism of dominant inhibition was direct binding of TRC40-DN to ribosomally released substrate. Due to deficient ATPase activity, TRC40-DN would prevent substrate targeting to or release at the ER membrane. To test this, we analyzed the interactions between Sec61b and endogenous TRC40 versus exogenously added (and epitope-tagged) TRC40-DN. At a level of TRC40-DN that inhibits TA insertion by 50%, crosslinks to the endogenous and exogenous proteins were roughly equal ( Figures  6E and 6F ). Higher levels of TRC40-DN resulted in increased crosslinking (at the expense of endogenous TRC40 crosslinks) that correlated with increased inhibition of Sec61b ( Figure 6F ). Upon addition of insertion-competent microsomes, Sec61b was released more efficiently from endogenous TRC40 than from exogenous TRC40-DN ( Figure 6G ). The unreleased TRC40-DN-substrate complex was found by sedimentation assays to be at least partially membrane bound (data not shown), suggesting that targeting may be normal, but ATPase-dependent release and subsequent insertion were blocked. Considered together, these findings suggest that TRC40 interacts directly with substrate, after which it delivers the TA protein to the membrane where its ATPase activity is necessary for substrate release, subsequent insertion, and recycling of TRC for another round of targeting.
A Working Model for TA Protein Insertion
The results in this study have led to the identification of the first component of a poorly characterized but widely used posttranslational pathway of membrane protein insertion. Our subsequent mechanistic analyses of TRC40 delineate a working framework for the principal steps in this targeting and insertion pathway (Figure 7 ) and identify specific, important directions for future studies.
Based on the sedimentation ( Figure 3F ), crosslinking ( Figure S3D ), and fractionation ( Figure S3E) analyses, TRC40 appears to be preassembled into the larger cytosolic TRC even in the absence of substrate. While this complex can be membrane bound (Figure 5 ), at least half of TRC appears to be free in the cytosol, awaiting ribosome-released TMD-containing substrates. This places TRC ''second in line'' behind SRP for TMD interaction. The affinity of SRP for ribosomes (Ogg and Walter, 1995) and its positioning relative to the ribosomal exit tunnel (Halic et al., 2004 ) provides a competitive advantage for nascent chain interactions. This advantage is lost upon translational termination, since TMD-containing polypeptides released into the cytosol appear to be preferentially bound to non-SRP-containing complexes ( Figure 2B and Figures S2C and S2D ), the principal one of which is TRC (whose abundance also appears to be greater than SRP's in reticulocyte lysate). How TRC out-competes chaperones such as Hsp70 remains unclear. One possibility is that while Hsp70 binds and releases from substrates in an ATPase-driven cycle (Mayer and Bukau, 2005) , the TRC40-substrate interaction is stable until its delivery to the membrane (e.g., Figure S2E ). Thus, we favor a model in which TRC acts as a ''trap'' to sequester cytosolic TMDcontaining substrates from other potential interacting partners that may serve to temporarily prevent substrate aggregation.
The mechanism underlying the specificity of TRC for TMDs remains to be determined. However, two points are worth noting. First, simple hydrophobicity is not likely to be the sole determinant since substrates containing a signal sequence, C-terminal GPI-anchoring signal, or a spontaneously inserting TMD were all poor substrates for TRC interaction, and were also not significantly inhibited by TRC40-DN ( Figure 4G ). Second, the interaction of TRC is not limited solely to TMDs at the extreme C terminus ( Figure 4D) . Thus, the TRC-dependent pathway may be utilized by not only TA proteins, but also membrane proteins that, for one reason or another, missed their opportunity to target via the SRP-dependent pathway. Of course, the TRC pathway presumably has many additional constraints and would fail to insert complex membrane proteins or those whose intended lumenal domains had already folded (such as Sec61b-CFP; Figure 4C ). But our demonstration that Nsyn1, with a tail of 154 residues, can not only interact with TRC40 ( Figure 4D ) but also be inserted posttranslationally ( Figure S4C ) provides one example of a membrane protein that can insert by both co-and posttranslational pathways that utilize different machineries and operate in parallel.
Once bound to a TMD-containing substrate in the cytosol, TRC presumably interacts with a putative receptor at the ER membrane. This interaction does not appear to be dependent on engaging a substrate since in-vitrosynthesized TRC40 can bind ER microsomes (data not shown). Furthermore, native ER microsomes contain prebound TRC40. Binding of substrate to TRC may enhance its interaction with the membrane receptor, but this needs to be further explored. An analogy to the SRP targeting system is applicable here: while SRP has an affinity for both empty ribosomes and its ER-bound receptor, the presence of a nascent chain substrate (and nucleotide) substantially enhances these interactions to favor efficient targeting without substantial competition by free SRP. We envisage an analogous situation for TRC (Figure 7) .
Release of substrate from TRC at the membrane is dependent on the ATPase activity of TRC40. At least three reactions must occur at this step. First, the ATPase activity of TRC40 is presumably stimulated by its receptor interaction. Second, substrate must be released from TRC40 upon ATP hydrolysis. Third, the released TMD must then either be inserted directly into the membrane or transferred to an ''insertase'' that mediates membrane integration of the TMD and translocation of the tail. It seems unlikely that insertion is ''spontaneous'' upon release from TRC40 given that even large regions of up to 154 residues can be translocated simultaneously with insertion.
The simplest model is that the putative receptor for TRC40 carries out all three activities by stimulating the TRC40 ATPase, binding to the substrate released from TRC40, and serving as the insertase.
Recently, the homolog of TRC40 in S. cerevisiae (termed Arr4 or Get3) has been implicated in a variety of processes, including Golgi-to-ER trafficking, ER-associated degradation, sporulation, regulation of ion transport, and tolerance to certain stresses (Shen et al., 2003; Schuldiner et al., 2005; Metz et al., 2006; Auld et al., 2006) . The relationship between these phenotypes in yeast and our demonstrated role of mammalian TRC40 in TA protein insertion remains unclear at present. One explanation is that Arr4/Get3 has a functional role or roles in yeast that are distinct from and unrelated to the TA insertion pathway. Alternatively, the conclusion by Auld et al. (2006) that all of these phenotypes are connected in some way to intracellular membrane composition and organization raises the possibility that partial defects in TA protein insertion might underlie some or all of these pleiotropic effects. If this were the case, one would have to postulate that another insertion pathway or pathways can compensate to a large degree in yeast (since Arr4/ Get3 deletion is not lethal), but not in mammals, where disruption of TRC40 shows early embryonic lethality (Mukhopadhyay et al., 2006) . Development of quantitative assays for TA protein insertion of multiple substrates in the yeast system will be needed to investigate these questions in depth and determine the extent to which the machinery of this translocation pathway is conserved across diverse species.
Toward this end, it is clear that identification of the complete TRC, as well as the membrane component or components that serve as the putative TRC receptor, represent important future goals. Our discovery of TRC40 as a central ATPase that coordinates the targeting and membrane insertion reactions should now greatly facilitate the purification of other pathway components. Once these are in hand, the process of posttranslational membrane protein insertion can be reconstituted with purified components to fully dissect its mechanistic basis. The cotranslational SRP pathway (left) is compared with the posttranslational pathway (right) mediated by the multicomponent TRC (whose ATPase TRC40 subunit is shown in red). The basic steps of substrate synthesis (1), recognition of the TMD (2), receptor-mediated targeting to the ER membrane (3), and nucleotide hydrolysis-dependent substrate release (4) are indicated in each pathway. The posttargeting step of TMD insertion is not depicted. The two pathways do not interfere or compete with each other due to the distinct mechanisms of SPR versus TRC function (see text for details). Thus, the substrate clienteles (and membrane-bound machinery) for the TRC-and SRP-dependent pathways are proposed to be distinct. Only certain unusual TA proteins with long tails would be capable of using both systems.
EXPERIMENTAL PROCEDURES
Materials
All constructs used in this study were made by standard methods and verified by sequencing. The initial cDNA for human TRC40 was obtained from Origene, and Nsyn1 from G. Gupta and B. Heath (Gupta et al., 2003) . A complete list of constructs and their composition is provided in Table S1 . Rabbit antisera to the N-and C-terminal regions of TRC40 and to the 3F4 epitope were generated by immunizing rabbits with KLH-conjugated synthetic peptides (see Figure 3D and Figure S1A ). Antibodies to GFP were raised against recombinant His-tagged GFP (from G. Patterson) expressed from the pRSETA vector in E. coli. This antiserum recognizes both the epitope tag and GFP, and was used for either purpose as indicated in the figure legends. Yeast RMs were a gift from T. Rapoport. Bovine liver microsomes and cytosol were prepared by differential centrifugation as for pancreatic RMs (Walter and Blobel, 1983) , except homogenization and fractionation was performed in physiologic salt buffer (100 mM KAc, 50 mM HEPES [pH 7.4], 2 mM MgAc 2 , 250 mM sucrose), and the sucrose cushion for the final centrifugation step was 0.8 M instead of 1.3 M. The sources of published or commercially available materials used in this study are provided in the Supplemental Data.
Insertion and Translocation Assays
Assays for cotranslational translocation (of Prl, PrP, GFP-fusions, and Nsyn1 constructs), posttranslational insertion (of Sec61b, Cb5, and various other TA-proteins), and posttranslational translocation (of a-factor and other proteins) have been described (Fons et al., 2003; Brambillasca et al., 2005; Panzner et al., 1995) . In general, co-and posttranslational reactions were for 30 min at 32 C. Unless otherwise indicated, an energy regenerating system (1 mM ATP, 1 mM GTP, 10 mM Creatine phosphate, and 40 mg/ml creatine kinase) was present during the incubation. Posttranslational reactions were generally performed on samples treated with a protein synthesis inhibitor, depleted of ribosomes by centrifugation (70,000 rpms for 30 min in a TL100.3 rotor), or both. Any modifications to these methods are indicated in the figure legends, with additional details provided in the Supplemental Data.
Sucrose Gradient Analyses
Gradients were 5%-25% (w/v) sucrose in physiological salt buffer (PSB; 100 mM KAc, 50 mM HEPES [pH 7.4], 2 mM MgAc 2 ). Sedimentation was for 5 hr at 55,000 rpm in a TLS-55 rotor (Beckman) at 4 C.
RNCs were isolated using 10%-50% (w/v) sucrose gradients in PSB spun for 1 hr at 55,000 rpms. Either 10 or 11 fractions were manually collected from the gradients and analyzed directly or subjected to further manipulations (such as crosslinking and insertion assays as described in individual figure legends).
Crosslinking Analyses
Samples for crosslinking (generally taken from the appropriate fraction or fractions of a sucrose gradient) were adjusted to between 20 and 500 mM BMH or DSS (as indicated in the figure legends) added from freshly prepared stocks in DMSO (whose final concentration in the reaction did not exceed 2%). BMH reactions were incubated on ice for 30 min, while DSS was reacted at room temperature for 30 min. Reactions were quenched with 100 mM 2-mercaptoethanol, 100 mM Tris, or both before either direct analysis or further processing (e.g., for immunoprecipitation).
Immunoaffinity Isolation and Identification of TRC40 A 0.2 to 0.5 ml column of anti-Sec61b (against the extreme N terminus) immobilized on Protein A agarose was washed briefly in 0.2 M glycine (pH 2.3) and equilibrated in PSB at 4 C. Translation reactions [either 1 ml (small scale) or 20 ml (large scale)] were depleted of ribosomes by centrifugation and passed over the resin (sometimes up to three times) at 4 C. The column was washed extensively with PSB, and in some cases, with PSB containing 250 mM KAc. Elution was with 1 mM peptide for 30 min at room temperature in PSB. For subsequent sucrose gradients, insertion analyses, or immunoblots, samples were used directly. For analysis by staining or high-sensitivity immunoblots, proteins were concentrated by precipitation with TCA in the presence of 0.5% Triton X-100 carrier, washed in acetone, and dissolved in 1% SDS. Bands were excised from Coomassie-stained gels for tryptic digests and mass spectrometry (performed by Midwest Bio Services).
Recombinant Expression and Purification
Expression in E. coli from the pRSETA vector was induced with IPTG, and the His-tagged protein (which was largely insoluble) was purified under denaturing conditions (with 4M urea) using immobilized Ni +2 (on chelating sepharose from Amersham). The protein was refolded on the column by washing extensively with PSB and eluted with imidazole in PSB before dialysis against PSB to remove imidazole.
Miscellaneous Methods
Immunoprecipitations in this study were always under denaturing conditions. After samples were heated in 1% SDS to 100 C, they were diluted 10-fold in IP buffer (1% Triton X-100, 50 mM HEPES [pH 7.4], 100 mM NaCl) at 4 C and immunoprecipitated as before (Fons et al., 2003) . Most analyses were on 12% Tris-Tricine gels containing 0.1% SDS. Some analyses ( Figure 3C , Figures S2C, S2D , and S3D) used 10% Tris-Glycine gels. Immunoblotting utilized nitrocellulose. Optimal antibody dilutions were determined empirically in preliminary experiments. Secondary antibodies were HRP-conjugated. Development was with chemiluminescence reagents from Pierce. Quantification of radiolabeled gels employed the Typhoon phosphorimager system with accompanying software. Figures were made from scanned films using Adobe Photoshop and Illustrator software.
Supplemental Data
The Supplemental Data for this article can be found online at http:// www.cell.com/cgi/content/full/128/6/1147/DC1/.
